Flemming W Bach Selected Research

Flemming W Bach Research Topics

Disease

28	Pain (Aches) 01/2021 - 04/2002
15	Neuralgia (Stump Neuralgia) 01/2021 - 07/2004
8	Polyneuropathies (Polyneuropathy) 01/2021 - 04/2001
5	Hyperalgesia 06/2006 - 04/2002
4	Spinal Cord Injuries (Spinal Cord Injury) 01/2017 - 04/2002
3	Migraine Disorders (Migraine) 04/2021 - 12/2006
3	Fibromyalgia (Fibrositis) 12/2016 - 02/2010
2	Headache (Headaches) 04/2021 - 01/2018
2	Ischemic Stroke 01/2019 - 12/2017
2	Multiple Sclerosis 06/2005 - 07/2004
1	Atherosclerosis 01/2019
1	Migraine with Aura (Familial Hemiplegic Migraine) 01/2018
1	Epilepsy (Aura) 01/2018
1	Hypercapnia 01/2018
1	Stroke (Strokes) 12/2017
1	Serotonin Syndrome (Syndrome, Serotonin) 01/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2016
1	Inflammation (Inflammations) 01/2016
1	Glioma (Gliomas) 11/2015
1	Autoimmune Diseases of the Nervous System 11/2015
1	Neurogenic Inflammation 02/2014
1	Myalgia 02/2014
1	Fabry Disease (Fabry's Disease) 09/2009
1	Small Fiber Neuropathy 06/2006
1	Peripheral Nerve Injuries 03/2006
1	Paresthesia (Dysesthesia) 05/2005
1	Stress Fractures (Stress Fracture) 04/2005
1	Chronic Pain 08/2004
1	Dizziness (Lightheadedness) 07/2004

Drug/Important Bio-Agent (IBA)

8	Analgesics (Analgesic Drugs)IBA 05/2013 - 08/2003
6	Imipramine (Janimine)FDA LinkGeneric 01/2021 - 08/2004
6	Pregabalin (Lyrica)FDA Link 12/2017 - 03/2011
5	Capsaicin (Zostrix)FDA Link 09/2009 - 03/2004
4	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2021 - 04/2001
4	Anticonvulsants (Antiepileptic Drugs)IBA 01/2017 - 12/2004
3	Sodium Channel BlockersIBA 10/2019 - 05/2005
3	Pain-FreeIBA 12/2016 - 02/2010
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2017 - 01/2016
2	Gabapentin (Neurontin)FDA LinkGeneric 01/2017 - 12/2004
2	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 10/2008
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2017 - 10/2008
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2015 - 03/2006
2	Vasoconstrictor AgentsIBA 09/2009 - 08/2008
2	Valproic Acid (Depakote)FDA LinkGeneric 07/2007 - 01/2004
2	Sodium Channels (Sodium Channel)IBA 03/2006 - 05/2005
2	Lidocaine (Xylocaine)FDA LinkGeneric 03/2006 - 05/2005
2	CannabinoidsIBA 06/2005 - 07/2004
2	Dronabinol (THC)FDA LinkGeneric 06/2005 - 07/2004
1	Hormones (Hormone)IBA 04/2021
1	Terbutaline (Brethaire)FDA LinkGeneric 01/2021
1	Lacosamide FDA Link 10/2019
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2019
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2019
1	Docosahexaenoic AcidsIBA 01/2019
1	Eicosapentaenoic AcidIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	Linoleic Acid (Linoleate)IBA 12/2017
1	CarbohydratesIBA 12/2017
1	danaparoid (Orgaran)FDA Link 12/2017
1	Monounsaturated Fatty AcidsIBA 12/2017
1	Medical MarijuanaIBA 01/2017
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2017
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 01/2017
1	Opioid Analgesics (Opioids)IBA 01/2017
1	EndocannabinoidsIBA 01/2016
1	AmidesIBA 01/2016
1	palmidrolIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 11/2015
1	Leucine (L-Leucine)FDA Link 11/2015
1	Surface Antigens (Surface Antigen)IBA 11/2015
1	AntibodiesIBA 11/2015
1	Type A Botulinum Toxins (Botox)FDA Link 02/2014
1	Glutamic Acid (Glutamate)FDA Link 02/2014
1	Chemokine ReceptorsIBA 05/2013
1	Levetiracetam (Keppra)FDA LinkGeneric 07/2011
1	alpha-Galactosidase (Beano)IBA 09/2009
1	Acetylcholine (Acetylcholine Chloride)FDA Link 09/2009
1	EnzymesIBA 09/2009
1	GlycolipidsIBA 09/2009
1	Escitalopram FDA Link 10/2008
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 07/2007
1	Sumatriptan (Imigran)FDA LinkGeneric 12/2006
1	Tryptamines (Triptans)IBA 12/2006
1	Ketamine FDA LinkGeneric 03/2006
1	AcetoneIBA 03/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2005
1	IceIBA 10/2004
1	Lamotrigine (Lamictal)FDA LinkGeneric 04/2002

Therapy/Procedure

5	Therapeutics 10/2019 - 05/2015
1	Aftercare (After-Treatment) 01/2018
1	Oral Administration 05/2013